Magnasense logotype


Brand Change Announcement: AegirBio AB has officially changed its name to Magnasense AB. The new website,, launched on 9 July 2024, with redirects from

Visit us at ACTRIMS 2020 and learn more about precision dosing of Tysabri (natalizumab)

Aegirbio will be at ACTRIMS from February 27-28, 2020 in West Palm Beach, Fl. Visit us at Booth #320

Aegirbio is a precision medicine company focused on therapeutic drug monitoring of biologic therapies.

Learn more about MoNATor – the first assay to measure the level of natalizumab circulating in blood. This information may help optimize treatment intervals, potentially reducing PML risk.

Physician flyer (pdf)

Information for Healthcare Providers

ACTRIMS 2019 poster (ppt)

MoNATor Test for Therapeutic Drug Monitoring of Natalizumab in Multiple Sclerosis Patients (PPT)

Interested in moNATor?

Come visit our Booth #320 or contact us for details: